Changes of the human skin microbiota upon chronic exposure to polycyclic aromatic hydrocarbon pollutants.


Journal

Microbiome
ISSN: 2049-2618
Titre abrégé: Microbiome
Pays: England
ID NLM: 101615147

Informations de publication

Date de publication:
26 06 2020
Historique:
received: 18 03 2020
accepted: 20 05 2020
entrez: 28 6 2020
pubmed: 28 6 2020
medline: 18 3 2021
Statut: epublish

Résumé

Polycyclic aromatic hydrocarbons (PAHs) are of environmental and public health concerns and contribute to adverse skin attributes such as premature skin aging and pigmentary disorder. However, little information is available on the potential roles of chronic urban PAH pollutant exposure on the cutaneous microbiota. Given the roles of the skin microbiota have on healthy and undesirable skin phenotypes and the relationships between PAHs and skin properties, we hypothesize that exposure of PAHs may be associated with changes in the cutaneous microbiota. In this study, the skin microbiota of over two hundred Chinese individuals from two cities in China with varying exposure levels of PAHs were characterized by bacterial and fungal amplicon and shotgun metagenomics sequencing. Skin site and city were strong parameters in changing microbial communities and their assembly processes. Reductions of bacterial-fungal microbial network structural integrity and stability were associated with skin conditions (acne and dandruff). Multivariate analysis revealed associations between abundances of Propionibacterium and Malassezia with host properties and pollutant exposure levels. Shannon diversity increase was correlated to exposure levels of PAHs in a dose-dependent manner. Shotgun metagenomics analysis of samples (n = 32) from individuals of the lowest and highest exposure levels of PAHs further highlighted associations between the PAHs quantified and decrease in abundances of skin commensals and increase in oral bacteria. Functional analysis identified associations between levels of PAHs and abundance of microbial genes of metabolic and other pathways with potential importance in host-microbe interactions as well as degradation of aromatic compounds. The results in this study demonstrated the changes in composition and functional capacities of the cutaneous microbiota associated with chronic exposure levels of PAHs. Findings from this study will aid the development of strategies to harness the microbiota in protecting the skin against pollutants. Video Abstract.

Sections du résumé

BACKGROUND
Polycyclic aromatic hydrocarbons (PAHs) are of environmental and public health concerns and contribute to adverse skin attributes such as premature skin aging and pigmentary disorder. However, little information is available on the potential roles of chronic urban PAH pollutant exposure on the cutaneous microbiota. Given the roles of the skin microbiota have on healthy and undesirable skin phenotypes and the relationships between PAHs and skin properties, we hypothesize that exposure of PAHs may be associated with changes in the cutaneous microbiota. In this study, the skin microbiota of over two hundred Chinese individuals from two cities in China with varying exposure levels of PAHs were characterized by bacterial and fungal amplicon and shotgun metagenomics sequencing.
RESULTS
Skin site and city were strong parameters in changing microbial communities and their assembly processes. Reductions of bacterial-fungal microbial network structural integrity and stability were associated with skin conditions (acne and dandruff). Multivariate analysis revealed associations between abundances of Propionibacterium and Malassezia with host properties and pollutant exposure levels. Shannon diversity increase was correlated to exposure levels of PAHs in a dose-dependent manner. Shotgun metagenomics analysis of samples (n = 32) from individuals of the lowest and highest exposure levels of PAHs further highlighted associations between the PAHs quantified and decrease in abundances of skin commensals and increase in oral bacteria. Functional analysis identified associations between levels of PAHs and abundance of microbial genes of metabolic and other pathways with potential importance in host-microbe interactions as well as degradation of aromatic compounds.
CONCLUSIONS
The results in this study demonstrated the changes in composition and functional capacities of the cutaneous microbiota associated with chronic exposure levels of PAHs. Findings from this study will aid the development of strategies to harness the microbiota in protecting the skin against pollutants. Video Abstract.

Identifiants

pubmed: 32591010
doi: 10.1186/s40168-020-00874-1
pii: 10.1186/s40168-020-00874-1
pmc: PMC7320578
doi:

Substances chimiques

Environmental Pollutants 0
Polycyclic Aromatic Hydrocarbons 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Pagination

100

Références

Int J Environ Res Public Health. 2014 Dec 25;12(1):322-34
pubmed: 25547400
Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14390-5
pubmed: 20660314
mBio. 2015 Sep 15;6(5):e01315-15
pubmed: 26374122
Cell Host Microbe. 2018 Jun 13;23(6):716-724
pubmed: 29902437
Nat Commun. 2018 Aug 17;9(1):3294
pubmed: 30120222
J Invest Dermatol. 2013 Sep;133(9):2152-60
pubmed: 23337890
Nat Commun. 2019 Oct 16;10(1):4703
pubmed: 31619666
BMC Res Notes. 2016 Feb 12;9:88
pubmed: 26868221
Drug Test Anal. 2014 Jun;6 Suppl 1:55-66
pubmed: 24817049
Infect Immun. 2004 Sep;72(9):5143-9
pubmed: 15322008
Microbiome. 2018 Feb 02;6(1):26
pubmed: 29394957
Bioresour Technol. 2010 May;101(10):3437-43
pubmed: 20093016
FEMS Microbiol Ecol. 2014 Apr;88(1):129-39
pubmed: 24372170
Front Cell Infect Microbiol. 2018 Oct 04;8:346
pubmed: 30338244
Cell. 2018 Feb 8;172(4):784-796.e18
pubmed: 29358051
Mar Pollut Bull. 2013 Sep 15;74(1):95-104
pubmed: 23928000
Microbiome. 2018 Nov 22;6(1):208
pubmed: 30466483
Cell Metab. 2018 Nov 6;28(5):737-749.e4
pubmed: 30057068
Nat Methods. 2013 Oct;10(10):996-8
pubmed: 23955772
Sci Rep. 2017 Nov 10;7(1):15329
pubmed: 29127390
Sci Rep. 2017 Sep 5;7(1):10567
pubmed: 28874721
Arch Toxicol. 2017 Jun;91(6):2331-2341
pubmed: 28378121
Genome Med. 2014 Dec 02;6(12):107
pubmed: 25587358
Nat Microbiol. 2016 Jul 11;1(9):16106
pubmed: 27562258
PeerJ. 2013 Mar 12;1:e53
pubmed: 23638391
Nature. 2013 Jun 20;498(7454):367-70
pubmed: 23698366
Microbiome. 2018 Jan 15;6(1):12
pubmed: 29335027
Biostatistics. 2014 Jul;15(3):569-83
pubmed: 24550197
Microbiol Mol Biol Rev. 2018 Sep 12;82(4):
pubmed: 30209071
Biometrics. 2015 Dec;71(4):1042-9
pubmed: 26038228
Int J Cosmet Sci. 2018 Oct;40(5):502-515
pubmed: 30192376
Cell. 2016 May 5;165(4):854-66
pubmed: 27153496
J Invest Dermatol. 2010 Dec;130(12):2719-26
pubmed: 20664556
Sci Adv. 2015 Apr 3;1(3):
pubmed: 26229982
PLoS One. 2014 Jul 09;9(7):e101438
pubmed: 25007154
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
mBio. 2015 Oct 20;6(5):e01578-15
pubmed: 26489866
Int J Cosmet Sci. 2018 Oct;40(5):467-481
pubmed: 30112861
Anal Chim Acta. 2017 Dec 1;995:65-76
pubmed: 29126482
Anal Bioanal Chem. 2016 Mar;408(8):1997-2008
pubmed: 26842747
Nat Methods. 2013 Dec;10(12):1200-2
pubmed: 24076764
Int J Syst Evol Microbiol. 2007 Sep;57(Pt 9):2114-2118
pubmed: 17766882
Psychometrika. 2017 May 23;:
pubmed: 28536930
Int J Syst Evol Microbiol. 2016 Nov;66(11):4422-4432
pubmed: 27488827
Nat Methods. 2015 Oct;12(10):902-3
pubmed: 26418763
Environ Sci Pollut Res Int. 2017 Feb;24(5):4591-4602
pubmed: 27957694
J Invest Dermatol. 2016 May;136(5):947-956
pubmed: 26829039
Forensic Sci Int. 2015 Apr;249:6-19
pubmed: 25553512
Exp Dermatol. 2017 Sep;26(9):835-838
pubmed: 28094891
Sci Rep. 2016 Dec 21;6:39491
pubmed: 28000755
Front Microbiol. 2017 Oct 06;8:1929
pubmed: 29056930
PLoS One. 2018 Feb 14;13(2):e0192898
pubmed: 29444186
J Appl Genet. 2017 Aug;58(3):321-330
pubmed: 27943120
BMC Genomics. 2013 Jun 10;14:390
pubmed: 23758874
Sci Adv. 2018 Feb 28;4(2):eaao4502
pubmed: 29507878
Environ Int. 2019 Aug;129:308-319
pubmed: 31150973
Environ Int. 2018 Dec;121(Pt 2):1341-1354
pubmed: 30420128
Nat Commun. 2018 Jan 25;9(1):377
pubmed: 29371662
Sci Rep. 2016 May 12;6:24877
pubmed: 27172459
Sci Adv. 2018 Mar 07;4(3):e1701581
pubmed: 29532031
Microbiome. 2016 Aug 24;4(1):46
pubmed: 27558504
Sci Transl Med. 2017 Feb 22;9(378):
pubmed: 28228596
Sci Rep. 2016 Mar 31;6:23745
pubmed: 27030383
Genome Biol. 2012 Apr 16;13(9):R79
pubmed: 23013615
Sci Rep. 2015 Jul 16;5:11845
pubmed: 26177982
Clin Biochem. 2008 Feb;41(3):152-61
pubmed: 18154730
Appl Environ Microbiol. 2014 Nov;80(21):6760-70
pubmed: 25172855
Environ Microbiol. 2006 Apr;8(4):732-40
pubmed: 16584484
NPJ Biofilms Microbiomes. 2017 Jun 22;3:14
pubmed: 28649415
Biostatistics. 2009 Jul;10(3):515-34
pubmed: 19377034
Indian J Dermatol Venereol Leprol. 2017 Jul-Aug;83(4):415-423
pubmed: 28195077
Front Microbiol. 2016 Aug 10;7:1235
pubmed: 27559331
Nature. 2014 Oct 2;514(7520):59-64
pubmed: 25279917

Auteurs

Marcus H Y Leung (MHY)

School of Energy and Environment, City University of Hong Kong, Hong Kong SAR, China.

Xinzhao Tong (X)

School of Energy and Environment, City University of Hong Kong, Hong Kong SAR, China.

Philippe Bastien (P)

L'Oréal Research and Innovation, Aulnay-sous-Bois, France.

Florent Guinot (F)

L'Oréal Research and Innovation, Aulnay-sous-Bois, France.

Arthur Tenenhaus (A)

CentraleSupelec-L2S-Laboratoire des signaux et systèmes, Brain and Spine Institute, Université Paris-Sud, Orsay, France.

Brice M R Appenzeller (BMR)

Human Biomonitoring Research Unit, Luxembourg Institute of Health, Strassen, Luxembourg.

Richard J Betts (RJ)

L'Oréal Research and Innovation, Pudong, China.

Sakina Mezzache (S)

L'Oréal Research and Innovation, Aulnay-sous-Bois, France.

Jing Li (J)

L'Oréal Research and Innovation, Pudong, China.

Nasrine Bourokba (N)

L'Oréal Research and Innovation, Singapore, Singapore.

Lionel Breton (L)

L'Oréal Research and Innovation, Aulnay-sous-Bois, France.

Cécile Clavaud (C)

L'Oréal Research and Innovation, Aulnay-sous-Bois, France.

Patrick K H Lee (PKH)

School of Energy and Environment, City University of Hong Kong, Hong Kong SAR, China. patrick.kh.lee@cityu.edu.hk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH